Updates are available Correction dated 2025-07-16
Click to view Correction: https://doi.org/10.1186/s13287-025-04529-6
-
Authors
Sun, Chenglu
Kong, Dejun
Qin, Hong
Li, Shilong
Wang, Conglin
Ren, Shaohua
Xu, Yini
Wang, Hongda
Wang, Hao https://orcid.org/0000-0001-9990-2714
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82071802)
National Natural Science Foundation of China (82270794)
Natural Science Foundation of Tianjin (21JCYBJC00850)
Science and Technology Project of Tianjin Health Commission (TJWJ2021MS004)
Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-076C)
- License Information
-
More Information
Article History
Received: 29 March 2025
Accepted: 14 May 2025
First Online: 2 June 2025
Change Date: 16 July 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s13287-025-04529-6
Declarations
:
: All the animal experiments were performed according to the Chinese Council on Animal Care guidelines and protocols approved by the Animal Ethical and Welfare Committee of Tianjin Medical University General Hospital (Tianjin, China). The title of the approved project was "Mechanisms of CD73 in Endometrial Regenerative Cell-Mediated Inhibition of Transplant Rejection and Tissue Injury" (Ethics No. IRB2022-DW-022, June 2022). The human material (menstrual blood) used in this study was reviewed and approved by the Ethics Committee of Tianjin Medical University General Hospital (Tianjin, China, IRB2022-WZ-084, June 2022), and informed consent was obtained from all the participants. The title of the approved project was "Mechanisms of CD73 in Endometrial Regenerative Cell-Mediated Inhibition of Transplant Rejection".
: The authors declare that they have no competing interests.
